Derazantinib
Derazantinib is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2, PDGFRβ, VEGFR and KIT.
| Trivial name | ARQ-087 |
| Catalog Number | S8609 |
| Molecular Formula | C29H29FN4O |
| CAS# | 1234356-69-4 |
| Inchi | InChI=1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1 |
| Inchi Key | KPJDVVCDVBFRMU-AREMUKBSSA-N |
| SMILES | COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F |
| Size | 25mg |
| Supplier Page | http://www.selleckchem.com/products/derazantinib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/derazantinib-arq-087-chemical-structure-s8609.gif |